Neuroprotective effects of kappa opioid receptor agonist in transient focal ischemia

被引:0
|
作者
Bhardwaj, A [1 ]
Toung, TJ [1 ]
Kirsch, JR [1 ]
Koehler, RC [1 ]
Hurn, PD [1 ]
Traystman, RJ [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P91
引用
收藏
页码:355 / 355
页数:1
相关论文
共 50 条
  • [21] Additive neuroprotective effects of dextrorphan and cycloheximide in rats subjected to transient focal cerebral ischemia
    Du, C
    Hu, R
    Csernansky, CA
    Liu, XZ
    Hsu, CY
    Choi, DW
    BRAIN RESEARCH, 1996, 718 (1-2) : 233 - 236
  • [22] Kappa-opioid receptor agonist protects the microcirculation of skeletal muscle from ischemia reperfusion injury
    Lin, Jeng-Yee
    Hung, Li-Man
    Lai, Lingo Yiling
    Wei, Fu-Chan
    ANNALS OF PLASTIC SURGERY, 2008, 61 (03) : 330 - 336
  • [23] Difelikefalin, a peripherally restricted kappa opioid receptor agonist, evokes diuresis through a central kappa opioid receptor pathway
    Meariman, Jacob
    Sutphen, Jane
    Gao, Juan
    Kapusta, Daniel
    FASEB JOURNAL, 2022, 36
  • [24] Neuroprotective effect of tyrosol on transient focal cerebral ischemia in rats
    Bu, Youngmin
    Rho, Seongjoo
    Kim, Jinmo
    Kim, Mi Yeon
    Lee, Dae Hee
    Kim, Sun Yeou
    Choi, Hoyoung
    Kim, Hocheol
    NEUROSCIENCE LETTERS, 2007, 414 (03) : 218 - 221
  • [25] REDUCED BRAIN TEMPERATURE DURING TRANSIENT FOCAL ISCHEMIA IS NEUROPROTECTIVE
    WHITE, RF
    FEUERSTEIN, G
    BARONE, FC
    FASEB JOURNAL, 1992, 6 (04): : A954 - A954
  • [26] Neuroprotective effect of curcumin on transient focal cerebral ischemia in rats
    Zhao, Jing
    Zhao, Yong
    Zheng, Weiping
    Lu, Yuyu
    Feng, Gang
    Yu, Shanshan
    BRAIN RESEARCH, 2008, 1229 : 224 - 232
  • [27] A comparison of the antinociceptive and adverse effects of a μ-opioid receptor agonist with a δ-opioid receptor agonist
    Gallantine, EL
    Kamali, F
    Meert, TF
    TOXICOLOGY, 2005, 213 (03) : 258 - 258
  • [28] THE EFFECTS OF SUBLINGUAL SALVINORIN A, A NATURALLY OCCURRING KAPPA OPIOID RECEPTOR AGONIST, IN HUMANS.
    Mendelson, J.
    Lopez, J.
    Baggott, M. J.
    Flower, K.
    Everhart, E.
    Munro, T.
    Galloway, G.
    Cohen, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S70 - S71
  • [29] Behavioral effects of the kappa opioid receptor partial agonist nalmefene in tests relevant to depression
    Browne, Caroline A.
    Smith, Tiffany
    Lucki, Irwin
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 872
  • [30] Partial kappa opioid receptor agonist effects in vivo in mice: Biased versus unbiased
    Guariglia, Catherine
    Dunn, Amelia
    Windisch, Kyle
    Butelman, Eduardo
    Reed, Brian
    Kreek, Mary Jeanne
    DRUG AND ALCOHOL DEPENDENCE, 2017, 171 : E78 - E79